1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Postdoctoral Fellowship Program from the BrightFocus Foundation funds young postdoctoral researchers pursuing pioneering studies on the biological causes and potential new clinical treatments for macular degeneration. Fellows must be conducting research in an established laboratory dedicated to advancing understanding of age-related macular degeneration and related conditions.
The award provides $100,000 per year for two years, totaling $200,000, to support salary and research costs. BrightFocus also funds postdoctoral work in Alzheimer's disease and glaucoma through parallel fellowship tracks. Eligible applicants are early-career postdoctoral researchers working at U.S. or international institutions.
Applications are submitted through the ProposalCentral portal, which requires prior organizational registration.
Get alerted about grants like this
Save a search for “BrightFocus Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Apply for a Research Grant | BrightFocus Foundation Apply for a Research Grant BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer’s disease, macular degeneration, and glaucoma.
Alzheimer’s Disease Research Request for Proposals → Macular Degeneration Research Request for Proposals → National Glaucoma Research Request for Proposals → To start a new application and upload attachments, you must use our ProposalCentral application portal to apply online. Note: Your organization must be registered with ProposalCentral to apply.
Macular Degeneration Research grant recipient, Yong-Su Kwon, PhD It is our firm belief that having the courage to invest in innovative ideas will lead to revolutionary therapies. BrightFocus provides initial funding for highly innovative experimental ideas, including interdisciplinary investigations that may apply to two or three of the BrightFocus disease interests.
Most of the awardees use the BrightFocus award funds to demonstrate key findings that lead to later interest and additional funding from industrial or governmental funding agencies. Grant Application Resources Frequently Asked Questions Get answers to applicants’ frequently asked questions, from eligibility to the review process, categorized by each disease program.
From file type and size to formatting requirements, ensure your application checks the necessary boxes. Your guide to understanding the conditions of funding and the definitions and abbreviations used throughout the grant agreement. National Glaucoma Research-funded scientist Ignacio Provencio, PhD.
Recent News & Breakthroughs Browse research news and breakthroughs from BrightFocus-funded scientists. Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference.
Focusing on the Future: Key Takeaways from the 2025 Glaucoma Fast Track BrightFocus Foundation’s 2025 Glaucoma Fast Track brought together early-career and established scientists to provide a thorough overview of the biology, diagnosis, and treatment of glaucoma.
Shaping the Future of Macular Degeneration Research: Key Takeaways from the 2025 AMD Fast Track Workshop BrightFocus Foundation’s 2025 Age-Related Macular Degeneration (AMD) Fast Track brought together early-career and established scientists to accelerate research toward a cure for AMD.
How Understanding Lipid Processing in the Eye Could Spark Innovative AMD Treatment Approaches With the help of funding from Macular Degeneration Research, Dr. Neetu Kushwah is studying the link between abnormal lipid regulation in the eye, inflammation, and age-related macular degeneration. Her findings could inspire new methods for treating the disease. Can Targeting the Immune System Slow the Progression of Alzheimer’s?
BrightFocus Alzheimer’s Disease Research grant recipient Joshua Emmerson, PhD, is exploring a certain type of immune cell’s unexpected role in Alzheimer’s disease—and what it could mean for protecting the brain.
BrightFocus Statement on Bipartisan Action to Protect Brain and Eye Research BrightFocus Foundation supports the bipartisan appropriations bill for fiscal year 2026, which provides critical federal funding for brain and eye research.
How Early Research Funding Is Transforming Glaucoma Detection If you’ve been diagnosed with glaucoma in the past 15 years, you have likely unknowingly witnessed what early research funding can do for the 4 million Americans living with this sight-stealing disease. Early Research Funding Is Essential to Saving Sight From Macular Degeneration Medicine’s biggest breakthroughs often start out as the smallest of ideas.
BrightFocus Foundation’s Macular Degeneration Research supports bold, early-stage science across a wide range of approaches. Unlocking the Brain’s Regenerative Potential to Fight Alzheimer’s María Llorens-Martín is investigating why the brain stops making new cells in Alzheimer’s—and how fixing that process could change lives.
Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference.
Focusing on the Future: Key Takeaways from the 2025 Glaucoma Fast Track BrightFocus Foundation’s 2025 Glaucoma Fast Track brought together early-career and established scientists to provide a thorough overview of the biology, diagnosis, and treatment of glaucoma.
Shaping the Future of Macular Degeneration Research: Key Takeaways from the 2025 AMD Fast Track Workshop BrightFocus Foundation’s 2025 Age-Related Macular Degeneration (AMD) Fast Track brought together early-career and established scientists to accelerate research toward a cure for AMD.
How Understanding Lipid Processing in the Eye Could Spark Innovative AMD Treatment Approaches With the help of funding from Macular Degeneration Research, Dr. Neetu Kushwah is studying the link between abnormal lipid regulation in the eye, inflammation, and age-related macular degeneration. Her findings could inspire new methods for treating the disease. Can Targeting the Immune System Slow the Progression of Alzheimer’s?
BrightFocus Alzheimer’s Disease Research grant recipient Joshua Emmerson, PhD, is exploring a certain type of immune cell’s unexpected role in Alzheimer’s disease—and what it could mean for protecting the brain.
BrightFocus Statement on Bipartisan Action to Protect Brain and Eye Research BrightFocus Foundation supports the bipartisan appropriations bill for fiscal year 2026, which provides critical federal funding for brain and eye research.
How Early Research Funding Is Transforming Glaucoma Detection If you’ve been diagnosed with glaucoma in the past 15 years, you have likely unknowingly witnessed what early research funding can do for the 4 million Americans living with this sight-stealing disease. Early Research Funding Is Essential to Saving Sight From Macular Degeneration Medicine’s biggest breakthroughs often start out as the smallest of ideas.
BrightFocus Foundation’s Macular Degeneration Research supports bold, early-stage science across a wide range of approaches. Unlocking the Brain’s Regenerative Potential to Fight Alzheimer’s María Llorens-Martín is investigating why the brain stops making new cells in Alzheimer’s—and how fixing that process could change lives.
Based on current listing details, eligibility includes: Young postdoctoral researchers conducting studies in an established laboratory focused on research contributing to understanding the biological causes and/or new clinical treatment of macular degeneration. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $100,000 per year for two years ($200,000 total) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.